中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy 期刊论文
CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 15, 页码: 3583-3592
作者:  Song, Jiangdian;  Shi, Jingyun;  Dong, Di;  Fang, Mengjie;  Zhong, Wenzhao;  Wang, Kun;  Wu, Ning;  Huang, Yanqi;  Liu, Zhenyu;  Cheng, Yue;  Gan, Yuncui;  Zhou, Yongzhao;  Zhou, Ping;  Chen, Bojiang;  Liang, Changhong;  Liu, Zaiyi;  Li, Weimin;  Tian, Jie
浏览  |  Adobe PDF(1305Kb)  |  收藏  |  浏览/下载：367/84  |  提交时间：2018/10/10
EGFR-TKI therapy  
Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments 期刊论文
CANCER LETTERS, 2018, 卷号: 414, 期号: 414, 页码: 230-238
作者:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
浏览  |  Adobe PDF(3002Kb)  |  收藏  |  浏览/下载：539/225  |  提交时间：2018/01/03
Programmed Cell Death Ligand-1  Near Infrared Fluorescence  Magnetic Resonance Imaging  Paclitaxel  Chemotherapy  Immunotherapy  
Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-Cu-64/IRDye800CW Allows Improved Breast Tumor Targeted Imaging and Therapy 期刊论文
MOLECULAR PHARMACEUTICS, 2017, 卷号: 14, 期号: 11, 页码: 3978-3986
作者:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Jin, Zhengyu;  Xue, Huadan;  Tian, Jie
浏览  |  Adobe PDF(4708Kb)  |  收藏  |  浏览/下载：404/139  |  提交时间：2018/01/03
Programmed Cell Death-i (Pd-i)  Near-infrared Fluorescence (Nirf) Imaging Pet Imaging  Doxorubicin (Dox)  Breast Cancer  Therapy  
Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model 期刊论文
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 卷号: 12, 期号: 12, 页码: 8337-8351
作者:  Du, Yang;  Sun, Ting;  Liang, Xiaolong;  Li, Yuan;  Jin, Zhengyu;  Xue, Huadan;  Wan, Yihong;  Tian, Jie
浏览  |  Adobe PDF(4726Kb)  |  收藏  |  浏览/下载：375/104  |  提交时间：2018/01/03
Pd-1  Programmed Cell Death-1  Near-infrared Fluorescence (Nirf)  Breast Cancer  Image-guided Surgery  Immunotherapy  Fluorescence Imaging